Tigermed is strongly committed to corporate compliance on both a local and global level. You may report concerns to Tigermed confidentially and anonymously by contact information below on matters related to Tigermed’s business activities.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
We are committed to supporting our clients in their clinical development in the best possible way.
The drug evaluation communication meetings in China are classified into 3 types according to newly issued “Drug R&D and Evaluation Communication Regulation”.
In this blog, we describe best practices in effective central laboratory and factors to take into account when selecting a central laboratory partner.
After the two rounds for seeking public comments in 2017 and 2019, The Technical Guidelines for Conditional Approval of Drugs was put into force by NMPA in Nov 2020.
We are committed to supporting our clients in their clinical development in the best possible way.